Overcoming Hormone Therapy Resistance with Sarki Abdulkadir, MD, PhD @NUFeinbergMed
Overcoming Hormone Therapy Resistance with Sarki Abdulkadir, MD, PhD  @NUFeinbergMed
Uploaded September 2024 | Updated November 2026, 1 day ago
The MYC oncogene is notorious in the cancer research world because it is implicated in many advanced or aggressive cancers such as treatment-resistant prostate cancer. In this episode, Sarki Abdulkadir, MD, PhD, shares how his team bucked the conventional notion that the MYC gene is “undruggable” and uncovered a handful of compounds that block MYC gene activity, making prostate cancer tumors sensitive to hormone therapy and opening up a potential new therapeutic target for treatment-resistant prostate cancer.

Learn more: spr.ly/6000oBULQ

-----------------------------------------

Visit the Feinberg website: https://www.feinberg.northwestern.edu/

SUBSCRIBE: spr.ly/60073dxlv

TWITTER (X): spr.ly/60003dxmj
INSTAGRAM: spr.ly/60083dxWi
FACEBOOK: spr.ly/60063dxW0
LINKEDIN: spr.ly/60063dxqG
Overcoming Hormone Therapy Resistance with Sarki Abdulkadir, MD, PhDCommitment to Scholarships at Northwestern University Feinberg School of MedicinePreventing older adult overdose: using data to identify touchpointsIs Antimicrobial Resistance Threatening Modern Medicine? with Jennie Kwon, DOThere is a Balm in Gilead: Healing Theologies and Practices in Black Spiritual SpacesA Day in the Life of Alumna Lizzie Van Doorn, PA-CMedical Research in CrisisSoil to Human Health: Connecting the Dots with Culinary MedicineWhy Its Important to Analyze Research Data by SexAdvancing Bioethics and Medical HumanitiesWhat is the Genetic Overlap Between Autism and Schizophrenia? with Peter Penzes, PhDWhy I Chose My Specialty - Vascular Surgery
Northwestern Univ. Feinberg School of Medicine |

Overcoming Hormone Therapy Resistance with Sarki Abdulkadir, MD, PhD

SHARE TO X SHARE TO REDDIT SHARE TO FACEBOOK WALLPAPER